Cargando...
The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy
The coming wave of patent expiries of first generation commercialized biotherapeutical drugs has seen the global market open its doors to close copies of these products. These near perfect substitutes, which are termed as “biosimilars”, do not need to undergo intense clinical trials for their approv...
Gardado en:
| Publicado en: | Biomolecules |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6770099/ https://ncbi.nlm.nih.gov/pubmed/31450637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9090410 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|